Hormone replacement therapy in postmenopausal women with schizophrenia: Positive effect on negative symptoms?

Biological Psychiatry

Volumn 49, Issue 1, 2001, Pages 47-51

  Lindamer, Laurie A ^a,b,c   Buse, Dawn C ^c   Lohr, James B ^a,b,c   Jeste, Dilip V ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Aging; Antipsychotics; Estrogen; Positive and negative symptoms; Psychosis

Indexed keywords

CHLORPROMAZINE; ESTROGEN; NEUROLEPTIC AGENT;

ADULT; AGED; AGING; ARTICLE; COGNITION; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFECT; DRUG INDUCED DISEASE; ESTROGEN THERAPY; FEMALE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MENTAL DISEASE; MOTOR DYSFUNCTION; NEGATIVE SYNDROME; ONSET AGE; POSTMENOPAUSE; PRIORITY JOURNAL; SCHIZOPHRENIA; TREATMENT OUTCOME;

ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 0035054491     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(00)00995-1     Document Type: Article

References (35)

1. Gender and affect in schizophrenia
2. Gender differences in schizophrenia
3. Cross-sectional study of older outpatients with schizophrenia and healthy comparison subjects: No differences in age-related cognitive decline
4. Mini-Mental State: A practical method for grading the cognitive state of patients for the clinician
5. Influence of the menstrual cycle phase on the therapeutic response in schizophrenia
6. Neuroendocrine aspects of tardive dyskinesia: The role of estrogen, prolactin, and dopamine
7. Gender and the expression of schizophrenia
8. Schizophrenia throughout life: Sex differences in severity and profile of symptoms
9. Generating and testing a causal explanation of the gender difference in age at first onset of schizophrenia
10. Variation in symptom severity over the menstrual cycle of schizophrenics
11. Development of a rating scale for primary depressive illness
12. Age-related differences in formal thought disorder in chronically hospitalized schizophrenic patients: A cross-sectional study across nine decades
13. Clinical and neuropsychological characteristics of patients with late-onset schizophrenia
14. The positive and negative syndrome scale (PANSS) for schizophrenia
15. Adjunctive estrogen treatment in women with schizophrenia
16. Gender, estrogen, and schizophrenia
17. Gender-related clinical differences in older patients with schizophrenia
18. Validating specific psychopathology scales in older schizophrenic outpatients
19. Effects of estrogen on mood and cognition in aging women
20. Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: A randomized controlled trial
21. Abnormal involuntary movement scale
22. The Brief Psychiatric Rating Scale (BPRS): Recent developments in ascertainment and scaling
23. Further evidence for a specific role of estradiol in schizophrenia?
24. The life course of schizophrenia: Age and symptom dimensions
25. Gender and the onset of schizophrenia: Neurohumoral influences
26. The role of estrogen in schizophrenia
27. Psychopathology in women and men: Focus on female hormones
28. Gender differences in the clinical expression of schizophrenia
29. A rating scale for extrapyramidal side effects
30. Sex differences in pharmacokinetics of psychotropic medications, part II: Effects on selected psychotropics